source
- Former FDA food safety chief warns nutrition push may overlook cyclospora outbreak risksSusan Mayne, who led the FDA’s Center for Food Safety and Applied Nutrition from 2015 to 2023, argues that nutrition and food safety cannot be treated separately. She says the two are linked and bo…
- Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrappedSanofi had hoped the acquisition of Kymab would fill a major hole that will be left as autoimmune juggernaut Dupixent heads toward a patent cliff. Now, another therapy has failed to meet expectations.BioSpace · 5d ago↗ source
- Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech